RCA Micro vs Resound Vivia 9 60S microRIE

The RCA Micro is a budget-priced behind-the-ear OTC hearing aid released in 2023, earning a C grade with a SoundScore of 2.7/5 in our lab testing. At $399, it sits in the lowest price tier of the OTC category but ranks last among the 65 OTC hearing aids we've tested. In our standardized testing, the RCA Micro shows a significant performance gap compared to category peers. Speech understanding scores are notably low, with speech in quiet at 1.0/5 (1.79 points below the category average) and speech in noise also at 1.0/5 (0.48 points below average). Music streaming scored 0.0/5, falling 1.92 points below the category average—meaning phone audio streaming is essentially non-functional as a feature. The one bright spot is excellent feedback handling at 5.0/5, which is 0.46 points above the category average, indicating stable performance without whistling during normal use. Own-voice comfort is mixed at 2.1/5, sitting 0.41 points below the category average. This suggests wearers may notice some unnatural quality to their own voice during conversations. At this price point, several alternatives deliver substantially stronger performance. The Elehear Beyond, Apple AirPods Pro 2, and Zepp Clarity Omni all fall within the same price range while scoring significantly higher in our testing. The RCA Micro's rechargeable batteries and simple BTE design offer basic convenience, but consumers seeking meaningful speech clarity improvements should consider higher-performing options in this competitive budget segment.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.